Clinical characteristics and prognosis of 16 relapsed/refractory B-cell malignancy patients with CAR T-cell-related hyperferritinaemia

With the success of chimeric antigen receptor-modified (CAR) T-cell therapy for relapsed/refractory (r/r) B-cell malignancies, severe complications after CAR T-cell infusion have emerged as nonnegligible prognosis-related factors. However, the prognosis of patients with CAR T-cell-related hyperferri...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Lanlan, Yu, Nanzhou, Li, Tongjuan, Ji, Hongyan, Jiang, Lijun, Wang, Di, Xu, Bin, Zhou, Xiaoxi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600326/
https://www.ncbi.nlm.nih.gov/pubmed/36313658
http://dx.doi.org/10.3389/fonc.2022.912689

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600326/
https://www.ncbi.nlm.nih.gov/pubmed/36313658
http://dx.doi.org/10.3389/fonc.2022.912689

Ejemplares similares